Report Highlights the Company’s Collaboration with GARDP to Develop NUZOLVENCE ® (zoliflodacin) for Oral Suspension for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results